A Safety Study of SYNT001 in Participants With Warm Autoimmune Hemolytic Anemia (WAIHA)

Stopped early · Phase 1/Phase 2

Conditions studied: Warm Autoimmune Hemolytic Anemia

In brief

This main study objective was to evaluate the safety and tolerability of intravenous (IV) SYNT001 (ALXN1830) in participants with WAIHA.

Key facts

Study ID

NCT03075878

Run by

Alexion Pharmaceuticals, Inc.

People needed

8

Starts

2018-01-10

Expected to finish

2019-08-06

Last updated by the study team

2020-05-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants had to meet the following criteria to be included:
• Willing and able to read, understand, and sign an informed consent form
• Confirmed diagnosis of WAIHA by enrolling physician
• Must have used medically acceptable contraception

You may not qualify if…

• Participants who met any of the following criteria were excluded:
• Participant unable or unwilling to comply with the protocol
• Active non-hematologic malignancy or history of non-hematologic malignancy in the 3 years prior to screening (exclusive of non-melanoma skin cancer and cervical cancer in situ)
• Positive for human immunodeficiency virus or hepatitis C antibody
• Positive for hepatitis B surface antigen
• Any exposure to an investigational drug or device within the 30 days prior to screening
• Intravenous immunoglobulin treatment within 30 days of screening
• Plasmapheresis or immunoadsorption within 30 days of screening
• Participant had any current medical condition that, in the opinion of the Investigator, may have compromised their safety or compliance, precluded successful conduct of the study, or interfered with interpretation of the results

Where it is running

• Alexion Study Site — Los Angeles, California, United States
• Alexion Study Site — San Francisco, California, United States
• Alexion Study Site — Boston, Massachusetts, United States
• Alexion Study Site — Pittsfield, Massachusetts, United States
• Alexion Study Site — Rochester, Minnesota, United States
• Alexion Study Site — Cleveland, Ohio, United States
• Alexion Study Site — Philadelphia, Pennsylvania, United States
• Alexion Study Site — Pittsburgh, Pennsylvania, United States
• Alexion Study Site — Seattle, Washington, United States
• Alexion Study Site — Amman, Jordan

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.